|Other names: Dysmenorrhoea, painful periods, menstrual cramps|
|Symptoms||Pain during menstruation, diarrhea, nausea|
|Usual onset||Within a year of the first menstrual period|
|Duration||Less than 3 days (primary dysmenorrhea)|
|Causes||No underlying problem, uterine fibroids, adenomyosis, endometriosis|
|Diagnostic method||Pelvic exam, ultrasound|
|Differential diagnosis||Ectopic pregnancy, pelvic inflammatory disease, interstitial cystitis, chronic pelvic pain|
|Treatment||Heating pad, medication|
|Medication||NSAIDs such as ibuprofen, hormonal birth control, IUD with progestogen|
|Prognosis||Often improves with age|
|Frequency||20–90% (women of reproductive age)|
Dysmenorrhea, also known as painful periods or menstrual cramps, is pain during menstruation. Its usual onset occurs around the time that menstruation begins. Symptoms typically last less than three days. The pain is usually in the pelvis or lower abdomen. Other symptoms may include back pain, diarrhea or nausea.
In young women, painful periods often occur without an underlying problem. In older women, it is more often due to an underlying issues such as uterine fibroids, adenomyosis or endometriosis. It is more common among those with heavy periods, irregular periods, whose periods started before twelve years of age or who have a low body weight. A pelvic exam in those who are sexually active and ultrasound may be useful to help in diagnosis. Conditions that should be ruled out include ectopic pregnancy, pelvic inflammatory disease, interstitial cystitis and chronic pelvic pain.
Dysmenorrhea occurs less often in those who exercise regularly and those who have children early in life. Treatment may include the use of a heating pad. Medications that may help include NSAIDs such as ibuprofen, hormonal birth control and the IUD with progestogen. Taking vitamin B1 or magnesium may help. Evidence for yoga, acupuncture and massage is insufficient. Surgery may be useful if certain underlying problems are present.
Estimates of the percentage of women of reproductive age affected vary from 20 to 90%. It is the most common menstrual disorder. Typically, it starts within a year of the first menstrual period. When there is no underlying cause, often the pain improves with age or following having a child.
Signs and symptoms
The main symptom of dysmenorrhea is pain concentrated in the lower abdomen or pelvis. It is also commonly felt in the right or left side of the abdomen. It may radiate to the thighs and lower back.
Symptoms often co-occurring with menstrual pain include nausea and vomiting, diarrhea, headache, dizziness, disorientation, fainting and fatigue. Symptoms of dysmenorrhea often begin immediately after ovulation and can last until the end of menstruation. This is because dysmenorrhea is often associated with changes in hormonal levels in the body that occur with ovulation. In particular, prostaglandins induce abdominal contractions that can cause pain and gastrointestinal symptoms. The use of certain types of birth control pills can prevent the symptoms of dysmenorrhea because they stop ovulation from occurring.
Dysmenorrhea can be classified as either primary or secondary based on the absence or presence of an underlying cause. Primary dysmenorrhea occurs without an associated underlying condition, while secondary dysmenorrhea has a specific underlying cause, typically a condition that affects the uterus or other reproductive organs.
During a woman's menstrual cycle, the endometrium thickens in preparation for potential pregnancy. After ovulation, if the ovum is not fertilized and there is no pregnancy, the built-up uterine tissue is not needed and thus shed.
Prostaglandins and leukotrienes are released during menstruation, due to the build up of omega-6 fatty acids. Release of prostaglandins and other inflammatory mediators in the uterus cause the uterus to contract and systemic symptoms such as nausea, vomiting, bloating and headaches to happen. These substances are thought to be a major factor in primary dysmenorrhea. When the uterine muscles contract, they constrict the blood supply to the tissue of the endometrium, which, in turn, breaks down and dies. These uterine contractions continue as they squeeze the old, dead endometrial tissue through the cervix and out of the body through the vagina. These contractions, and the resulting temporary oxygen deprivation to nearby tissues, are responsible for the pain or cramps experienced during menstruation.
Compared with other women, women with primary dysmenorrhea have increased activity of the uterine muscle with increased contractility and increased frequency of contractions.
The diagnosis of dysmenorrhea is usually made simply on a medical history of menstrual pain that interferes with daily activities. However, there is no universally accepted gold standard technique for quantifying the severity of menstrual pains. Yet, there are quantification models, called menstrual symptometrics, that can be used to estimate the severity of menstrual pains as well as correlate them with pain in other parts of the body, menstrual bleeding and degree of interference with daily activities.
Once a diagnosis of dysmenorrhea is made, further workup is required to search for any secondary underlying cause of it, in order to be able to treat it specifically and to avoid the aggravation of a perhaps serious underlying cause.
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, are effective in relieving the pain of primary dysmenorrhea. They can have side effects of nausea, dyspepsia, peptic ulcer, and diarrhea.
Hormonal birth control
Use of hormonal birth control may improve symptoms of primary dysmenorrhea. A 2009 systematic review however found limited evidence that the birth control pill, containing low doses or medium doses of oestrogen, reduces pain associated with dysmenorrhea. In addition, no differences between different birth control pill preparations were found.
A review indicated the effectiveness of transdermal nitroglycerin. Reviews indicated the effectiveness of magnesium supplementation. A review indicated the usefulness of using calcium channel blockers.
There is insufficient evidence to recommend the use of many herbal or dietary supplements for treating dysmenorrhea, including, melatonin, vitamin E, fennel, dill, chamomile, cinnamon, damask rose, rhubarb, guava, and uzara. Further research is recommended to follow up on weak evidence of benefit for: fenugreek, ginger, valerian, zataria, zinc sulphate, fish oil, and vitamin B1. A 2016 review found that evidence of safety is insufficient for most dietary supplements. There is some evidence for the use of fenugreek.
One review found thiamine and vitamin E to be likely effective. It found the effects of fish oil and vitamin B12 to be unknown. Reviews found tentative evidence that ginger powder may be effective for primary dysmenorrhea. Reviews have found promising evidence for Chinese herbal medicine for primary dysmenorrhea, but that the evidence was limited by its poor methodological quality.
A 2016 Cochrane review of acupuncture for dysmenorrhea concluded that it is unknown if acupuncture or acupressure is effective. There were also concerns of bias in study design and in publication, insufficient reporting (few looked at adverse effects), and that they were inconsistent. There are conflicting reports in the literature, including one review which found that acupressure, topical heat, and behavioral interventions are likely effective. It found the effect of acupuncture and magnets to be unknown.
A 2007 systematic review found some scientific evidence that behavioral interventions may be effective, but that the results should be viewed with caution due to poor quality of the data.
Spinal manipulation does not appear to be helpful. Although claims have been made for chiropractic care, under the theory that treating subluxations in the spine may decrease symptoms, a 2006 systematic review found that overall no evidence suggests that spinal manipulation is effective for treatment of primary and secondary dysmenorrhea.
A 2011 review stated that high-frequency transcutaneous electrical nerve stimulation may reduce pain compared with sham TENS, but seems to be less effective than ibuprofen. A 2020 review indicated that transcutaneous electrical nerve stimulation is effective in reducing pain, decreasing the use of analgesics, and improving the quality of life in primary dysmenorrhea patients. 
Dysmenorrhea is estimated to affect approximately 25% of women. Reports of dysmenorrhea are greatest among individuals in their late teens and 20s, with reports usually declining with age. The prevalence in adolescent females has been reported to be 67.2% by one study and 90% by another. It has been stated that there is no significant difference in prevalence or incidence between races. Yet, a study of Hispanic adolescent females indicated a high prevalence and impact in this group. Another study indicated that dysmenorrhea was present in 36.4% of participants, and was significantly associated with lower age and lower parity. Childbearing is said to relieve dysmenorrhea, but this does not always occur. One study indicated that in nulliparous women with primary dysmenorrhea, the severity of menstrual pain decreased significantly after age 40. A questionnaire concluded that menstrual problems, including dysmenorrhea, were more common in females who had been sexually abused.
A survey in Norway showed that 14 percent of females between the ages of 20 to 35 experience symptoms so severe that they stay home from school or work. Among adolescent girls, dysmenorrhea is the leading cause of recurrent short-term school absence.
- Osayande AS, Mehulic S (March 2014). "Diagnosis and initial management of dysmenorrhea". American Family Physician. 89 (5): 341–6. PMID 24695505.
- American College of Obstetricians and Gynecologists (Jan 2015). "FAQ046 Dynsmenorrhea: Painful Periods" (PDF). Archived (PDF) from the original on 27 June 2015. Retrieved 26 June 2015.
- "Menstruation and the menstrual cycle fact sheet". Office of Women's Health. December 23, 2014. Archived from the original on 26 June 2015. Retrieved 25 June 2015.
- "Dysmenorrhea and Endometriosis in the Adolescent". ACOG. American College of Obstetricians and Gynecologists. 20 November 2018. Retrieved 21 November 2018.
- "Dysmenorrhea". www.hopkinsmedicine.org. Retrieved 2019-10-04.
- "Period pain". nhs.uk. 2017-10-19. Retrieved 2019-10-04.
- "Using Foods Against Menstrual Pain". Physicians Committee for Responsible Medicine. Retrieved 2019-10-04.
- Gomathy N, Dhanasekar KR, Trayambak D, Amirtha R (2019). "Supportive therapy for dysmenorrhea: Time to look beyond mefenamic acid in primary care". J Family Med Prim Care. 8 (11): 3487–3491. PMID 31803641.CS1 maint: uses authors parameter (link)
- Laura A Payne, Andrea J Rapkin, Laura C Seidman, Lonnie K Zeltzer, and Jennie CI Tsao (2017). "Experimental and procedural pain responses in primary dysmenorrhea: a systematic review". J Pain Res. 10: 2233–2246. PMID 29066929.CS1 maint: uses authors parameter (link)
- "Period Pain". MedlinePlus. National Library of Medicine. March 1, 2018. Retrieved November 7, 2018.
- Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D'Hooghe TM (2013). "Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review". Human Reproduction Update. 19 (5): 570–82. doi:10.1093/humupd/dmt016. PMID 23727940.
- Hilário SG, Bozzini N, Borsari R, Baracat EC (January 2009). "Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients". Fertility and Sterility. 91 (1): 240–3. doi:10.1016/j.fertnstert.2007.11.006. PMID 18249392.
- Nabeshima H, Murakami T, Nishimoto M, Sugawara N, Sato N (2008). "Successful total laparoscopic cystic adenomyomectomy after unsuccessful open surgery using transtrocar ultrasonographic guiding". Journal of Minimally Invasive Gynecology. 15 (2): 227–30. doi:10.1016/j.jmig.2007.10.007. PMID 18312998.
- Hacker, Neville F., J. George Moore, and Joseph C. Gambone. Essentials of Obstetrics and Gynecology, 4th ed. Elsevier Saunders, 2004. ISBN 0-7216-0179-0[page needed]
- Fenakel K, Lurie S. (1990). "The use of calcium channel blockers in obstetrics and gynecology; a review". Eur J Obstet Gynecol Reprod Biol. 37 (3): 199–203. doi:10.1016/0028-2243(90)90025-v. PMID 2227064.CS1 maint: uses authors parameter (link)
- Harel Z (December 2006). "Dysmenorrhea in adolescents and young adults: etiology and management". Journal of Pediatric and Adolescent Gynecology. 19 (6): 363–71. doi:10.1016/j.jpag.2006.09.001. PMID 17174824.
- Bofill Rodriguez, M; Lethaby, A; Farquhar, C (19 September 2019). "Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding". The Cochrane Database of Systematic Reviews. 9: CD000400. doi:10.1002/14651858.CD000400.pub4. PMC 6751587. PMID 31535715.
- Wright, Jason and Solange Wyatt. The Washington Manual Obstetrics and Gynecology Survival Guide. Lippincott Williams and Wilkins, 2003. ISBN 0-7817-4363-X[page needed]
- Rosenwaks Z, Seegar-Jones G (October 1980). "Menstrual pain: its origin and pathogenesis". The Journal of Reproductive Medicine. 25 (4 Suppl): 207–12. PMID 7001019.
- Wyatt KM, Dimmock PW, Hayes-Gill B, Crowe J, O'Brien PM (July 2002). "Menstrual symptometrics: a simple computer-aided method to quantify menstrual cycle disorders". Fertility and Sterility. 78 (1): 96–101. doi:10.1016/s0015-0282(02)03161-8. PMID 12095497.
- Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M (July 2015). "Nonsteroidal anti-inflammatory drugs for dysmenorrhoea". The Cochrane Database of Systematic Reviews (7): CD001751. doi:10.1002/14651858.CD001751.pub3. PMC 6953236. PMID 26224322.
- Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3
- Archer DF (November 2006). "Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives". Contraception. 74 (5): 359–66. doi:10.1016/j.contraception.2006.06.003. PMID 17046376.
- Wong CL, Farquhar C, Roberts H, Proctor M (October 2009). "Oral contraceptive pill for primary dysmenorrhoea". The Cochrane Database of Systematic Reviews (4): CD002120. doi:10.1002/14651858.CD002120.pub3. PMC 7154221. PMID 19821293.
- Power J, French R, Cowan F (July 2007). Power J (ed.). "Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy" (PDF). The Cochrane Database of Systematic Reviews (3): CD001326. doi:10.1002/14651858.CD001326.pub2. PMID 17636668.
- Glasier, Anna (2006). "Contraception". In DeGroot, Leslie J.; Larry, Jameson J. (eds.). Endocrinology (5th ed.). Philadelphia: Elsevier Saunders. pp. 2993–3003. ISBN 978-0-7216-0376-6. Unknown parameter
- Loose, Davis S.; Stancel, George M. (2006). "Estrogens and Progestins". In Brunton, Laurence L.; Lazo, John S.; Parker, Keith L. (eds.). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11th ed.). New York: McGraw-Hill. pp. 1541–1571. ISBN 978-0-07-142280-2. Unknown parameter
- Gupta HP, Singh U, Sinha S (July 2007). "Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device". Journal of the Indian Medical Association. 105 (7): 380, 382–5. PMID 18178990.
- Morgan PJ, Kung R, Tarshis J (May 2002). "Nitroglycerin as a uterine relaxant: a systematic review". Journal of Obstetrics and Gynaecology Canada. 24 (5): 403–9. doi:10.1016/S1701-2163(16)30403-0. PMID 12196860.
- Parazzini F, Di Martino M, Pellegrino P (2017). "Magnesium in the gynecological practice: a literature review". Magnes Res. 30 (1): 1–7. doi:10.1684/mrh.2017.0419. PMID 28392498.CS1 maint: uses authors parameter (link)
- Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, Marjoribanks J (March 2016). "Dietary supplements for dysmenorrhoea". The Cochrane Database of Systematic Reviews. 3: CD002124. doi:10.1002/14651858.CD002124.pub2. PMID 27000311.
- Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A (2017). "A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion". Mol Nutr Food Res. 61 (6): 1600950. doi:10.1002/mnfr.201600950. PMID 28266134.CS1 maint: uses authors parameter (link)
- Latthe PM, Champaneria R, Khan KS (February 2011). "Dysmenorrhoea". BMJ Clinical Evidence. 2011. PMC 3275141. PMID 21718556.
- Daily JW, Zhang X, Kim DS, Park S (December 2015). "Efficacy of Ginger for Alleviating the Symptoms of Primary Dysmenorrhea: A Systematic Review and Meta-analysis of Randomized Clinical Trials". Pain Medicine. 16 (12): 2243–55. doi:10.1111/pme.12853. PMID 26177393.
- Zhu X, Proctor M, Bensoussan A, Wu E, Smith CA (April 2008). Zhu X (ed.). "Chinese herbal medicine for primary dysmenorrhoea". The Cochrane Database of Systematic Reviews (2): CD005288. doi:10.1002/14651858.CD005288.pub3. PMID 18425916.
- Gao L, Jia C, Zhang H, Ma C (October 2017). "Wenjing decoction (herbal medicine) for the treatment of primary dysmenorrhea: a systematic review and meta-analysis". Archives of Gynecology and Obstetrics. 296 (4): 679–689. doi:10.1007/s00404-017-4485-7. PMID 28791471.
- Smith CA, Armour M, Zhu X, Li X, Lu ZY, Song J (April 2016). "Acupuncture for dysmenorrhoea". The Cochrane Database of Systematic Reviews. 4: CD007854. doi:10.1002/14651858.CD007854.pub3. PMID 27087494.
- Proctor ML, Murphy PA, Pattison HM, Suckling J, Farquhar CM (July 2007). Proctor M (ed.). "Behavioural interventions for primary and secondary dysmenorrhoea" (PDF). The Cochrane Database of Systematic Reviews (3): CD002248. doi:10.1002/14651858.CD002248.pub3. PMID 17636702.
- Chapman-Smith D (2000). "Scope of practice". The Chiropractic Profession: Its Education, Practice, Research and Future Directions. West Des Moines, IA: NCMIC. ISBN 978-1-892734-02-0.[page needed]
- Proctor ML, Hing W, Johnson TC, Murphy PA (July 2006). Proctor M (ed.). "Spinal manipulation for primary and secondary dysmenorrhoea". The Cochrane Database of Systematic Reviews. 3 (3): CD002119. doi:10.1002/14651858.CD002119.pub3. PMC 6718213. PMID 16855988.
- Elboim-Gabyzon M, Kalichman L (2020). "Transcutaneous Electrical Nerve Stimulation (TENS) for Primary Dysmenorrhea: An Overview". Int J Womens Health. doi:10.2147/IJWH.S220523. PMID 32021488.CS1 maint: uses authors parameter (link)
- Ramirez C, Donnellan N. (2017). "Pelvic denervation procedures for dysmenorrhea". Curr Opin Obstet Gynecol. 29 (4): 225–230. doi:10.1097/GCO.0000000000000379. PMID 28683027.CS1 maint: uses authors parameter (link)
- Holder, Andre; Edmundson, Laurel D; Erogul, Mert (31 December 2009). "Dysmenorrhea". eMedicine. Archived from the original on 2011-02-22. Unknown parameter
- Sharma P, Malhotra C, Taneja DK, Saha R (February 2008). "Problems related to menstruation amongst adolescent girls". Indian Journal of Pediatrics. 75 (2): 125–9. doi:10.1007/s12098-008-0018-5. PMID 18334791.
- Banikarim C, Chacko MR, Kelder SH (December 2000). "Prevalence and impact of dysmenorrhea on Hispanic female adolescents". Archives of Pediatrics & Adolescent Medicine. 154 (12): 1226–9. doi:10.1001/archpedi.154.12.1226. PMID 11115307.
- Sule ST, Umar HS, Madugu NH (June 2007). "Premenstrual symptoms and dysmenorrhoea among Muslim women in Zaria, Nigeria". Annals of African Medicine. 6 (2): 68–72. doi:10.4103/1596-3519.55713. PMID 18240706.
- Juang CM, Yen MS, Horng HC, Cheng CY, Yuan CC, Chang CM (October 2006). "Natural progression of menstrual pain in nulliparous women at reproductive age: an observational study". Journal of the Chinese Medical Association. 69 (10): 484–8. doi:10.1016/S1726-4901(09)70313-2. PMID 17098673.
- Vink CW, Labots-Vogelesang SM, Lagro-Janssen AL (August 2006). "[Menstruation disorders more frequent in women with a history of sexual abuse]". Nederlands Tijdschrift voor Geneeskunde (in Dutch). 150 (34): 1886–90. PMID 16970013.CS1 maint: unrecognized language (link)
- "Mozon: Sykemelder seg på grunn av menssmerter". Mozon. 2004-10-25. Archived from the original on 2007-03-17. Retrieved 2007-02-02.
- French L (2008). "Dysmenorrhea in adolescents: diagnosis and treatment". Paediatric Drugs. 10 (1): 1–7. doi:10.2165/00148581-200810010-00001. PMID 18162003.
|Wikimedia Commons has media related to [[commons:Lua error in Module:WikidataIB at line 506: attempt to index field 'wikibase' (a nil value).|Lua error in Module:WikidataIB at line 506: attempt to index field 'wikibase' (a nil value).]].|